Yuping Ge

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Inavolisib and lenvatinib for PIK3CA-mutated refractory splenic angiosarcoma: a case report.

Inavolisib and lenvatinib for PIK3CA-mutated refractory splenic angiosarcoma: a case report.

Journal: Anti-cancer drugs
Published: April 15, 2026

Assessing Graded Histological Regression as Basis for Treatment Modification after Neoadjuvant Therapy in LAGC: An Exploratory Phase II Study.

Assessing Graded Histological Regression as Basis for Treatment Modification after Neoadjuvant Therapy in LAGC: An Exploratory Phase II Study.

Journal: Annals of surgical oncology
Published: April 13, 2026

Cellular Senescence in Gastric Cancer: Molecular Mechanisms, Microenvironment Remodeling and Therapeutic Implications.

Cellular Senescence in Gastric Cancer: Molecular Mechanisms, Microenvironment Remodeling and Therapeutic Implications.

Journal: Aging and disease
Published: December 25, 2025

Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study.

Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study.

Journal: Frontiers in immunology
Published: August 17, 2024

Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer.

Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer.

Journal: Heliyon
Published: February 02, 2024

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.

Journal: BMC cancer
Published: May 11, 2023

The prognostic role of WeChat-based instant doctor-patient communication in patients with advanced pancreatic cancer.

The prognostic role of WeChat-based instant doctor-patient communication in patients with advanced pancreatic cancer.

Journal: Journal of cancer survivorship : research and practice
Published: May 07, 2023

Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy.

Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy.

Journal: Frontiers in oncology
Published: March 29, 2023

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.

Journal: Frontiers in immunology
Published: December 16, 2022

Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people.

Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 19, 2021

The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer.

The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer.

Journal: Frontiers in oncology
Published: September 23, 2021

Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.

Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.

Journal: BMC pulmonary medicine
Published: April 26, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026